Two independent clinical trials demonstrate the safety of stem cell therapies for Parkinson's disease. The papers, published ...

Both studies, which are reporting the results of early-stage clinical trials, show that the interventions were safe, and that ...

Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

These organoids provide scientists with better models for studying liver biology, and for developing treatments for various liver disorders.

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

In the short term, these multi-zonal liver organoids will help scientists shed new light on diseases including diabetes, drug-induced liver injury, alcohol-related liver disease, and viral hepatitis.

As we age, blood stem cells, the essential source of new blood cells in the body, can accumulate genetic mutations.

One reason why our livers excel at clearing waste from our blood system is that the organ functions according to three key ...

New research suggests that decreased activity of ELOVL2 -- a key enzyme in lipid metabolism -- accelerates white blood cell aging and alters genes associated with the onset of blood cancers.

Texas Tech University researchers used liquid chromatography–tandem mass spectrometry to quantify glucose transporter 1 (GLUT1) in mammalian brain cells.